Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Shield Thera (STX) Share Price

Price 9.10p on 04-03-2026 at 19:35:08
Change -0.31p -3.32%
Buy 9.20p
Sell 9.00p
Last Trade: Sell 15,000.00 at 9.04p
Day's Volume: 1,284,896
Last Close: 9.04p
Open: 9.35p
ISIN: GB00BYV81293
Day's Range 9.04p - 9.04p
52wk Range: 2.20p - 12.35p
Market Capitalisation: £96.55m
VWAP: 9.177838p
Shares in Issue: 1.07b

Shield Thera (STX) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 15,000 9.04p Uncrossing Trade
16:35:13 - 04-Mar-26
Sell* 10,985 9.04p Ordinary
16:19:43 - 04-Mar-26
Buy* 100 9.20p SI Trade
16:13:11 - 04-Mar-26
Buy* 36 9.20p SI Trade
16:13:11 - 04-Mar-26
Buy* 543 9.20p SI Trade
16:13:11 - 04-Mar-26
Buy* 543 9.20p SI Trade
16:13:11 - 04-Mar-26
Buy* 9 9.20p SI Trade
16:13:11 - 04-Mar-26
Buy* 21 9.20p SI Trade
16:13:11 - 04-Mar-26
Sell* 27,446 9.0723p Ordinary
16:13:02 - 04-Mar-26
Sell* 50,000 9.00p Ordinary
16:12:59 - 04-Mar-26
See more Shield Thera trades

Shield Thera (STX) Share Price History

Time period:
to
Date Open High Low Close Volume
4th Mar 2026 (Wed) 9.35 9.04 9.04 9.04 1,284,896
3rd Mar 2026 (Tue) 9.85 9.85 9.35 9.35 1,586,828
2nd Mar 2026 (Mon) 10.00 9.75 9.25 9.75 2,533,173
27th Feb 2026 (Fri) 10.00 10.00 10.00 10.00 680,729
26th Feb 2026 (Thu) 10.00 10.00 9.75 10.00 1,065,964
25th Feb 2026 (Wed) 9.75 10.00 9.75 10.00 1,300,737
24th Feb 2026 (Tue) 9.75 9.75 9.75 9.75 494,810
23rd Feb 2026 (Mon) 9.65 9.75 9.65 9.75 1,761,379
20th Feb 2026 (Fri) 9.75 9.75 9.65 9.65 1,415,300
19th Feb 2026 (Thu) 10.05 10.25 9.75 9.75 3,353,266
18th Feb 2026 (Wed) 10.25 10.25 9.80 10.05 1,585,797
17th Feb 2026 (Tue) 10.25 10.25 10.15 10.15 994,165
16th Feb 2026 (Mon) 10.75 10.75 10.50 10.50 1,020,214
13th Feb 2026 (Fri) 10.50 10.60 10.60 10.60 2,101,668
12th Feb 2026 (Thu) 10.50 10.50 10.40 10.50 216,854
11th Feb 2026 (Wed) 10.75 10.75 10.50 10.50 235,336
10th Feb 2026 (Tue) 10.50 10.75 10.50 10.75 1,127,333
9th Feb 2026 (Mon) 10.50 11.00 10.10 11.00 2,472,300
6th Feb 2026 (Fri) 10.00 10.00 9.25 9.60 1,944,396
5th Feb 2026 (Thu) 10.10 10.25 10.00 10.00 606,645
See more Shield Thera price history

Shield Thera (STX) Regulatory News

Date Source Headline
3rd Mar 2026 7:00 am RNS Chinese NMPA Accepts MAA Submission for ACCRUFeR®
27th Feb 2026 7:00 am RNS Total Voting Rights
9th Feb 2026 7:00 am RNS FDA Grants additional Exclusivity for ACCRUFeR
30th Jan 2026 7:05 am RNS Total Voting Rights
30th Jan 2026 7:00 am RNS Approval for ACCRUFeR in China expected in Q1 2026
21st Jan 2026 7:00 am RNS Q4 2025 Trading Update
2nd Jan 2026 11:06 am RNS Block listing 6 Monthly Return
2nd Jan 2026 7:00 am RNS Total Voting Rights
2nd Jan 2026 7:00 am RNS Total Voting Rights
22nd Dec 2025 7:00 am RNS FDA approves extension for ACCRUFeR®
See more Shield Thera regulatory news

Shield Thera (STX) Share News

IN BRIEF: Shield Therapeutics gets three more years of US exclusivity

9th Feb 2026 11:20

Shield Therapeutics PLC - Newcastle, England-based commercial-stage pharmaceutical company - Says the US Food & Drug Administration grants an additional three years of data exclusivity for Accrufer. The exclusivity remains in place until December 19, 2028, in addition to the Accrufer/Feraccru patent coverage valid until the mid-2030s. Read More

EARNINGS AND TRADING: Peel Hunt upbeat; Transense cuts profit outlook

30th Jan 2026 16:12

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

Shield Therapeutics reaches cash flow positivity as revenue grows

21st Jan 2026 16:24

(Alliance News) - Shield Therapeutics PLC on Wednesday said it achieved operating cash flow positivity in the fourth quarter of 2025, as it guided an operating profit in 2026. Read More

EARNINGS AND TRADING: Corel loss widens; Christie sells Vennersys

22nd Dec 2025 15:38

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

Shield Therapeutics upbeat as Accrufer trial initiated in Japan

14th Nov 2025 12:08

(Alliance News) - Shield Therapeutics PLC on Friday reported the commencement of a phase two Accrufer trial in Japan for the treatment of pulmonary arterial hypertension. Read More

See more Shield Thera news
FTSE 100 Latest
Value10,567.65
Change83.52

Login to your account

Forgot Password?

Not Registered